Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Protein linked to prognosis of adenocarcinomas of the lung

Nov. 18, 2011

EZN-3042 administered with docetaxel in phase I study

Nov. 18, 2011

Anti-alpha-V/beta-6 antibody inhibits liver fibrosis

Nov. 18, 2011

ONO-2952 emerges as a potential treatment for stress-related disorders

Nov. 18, 2011

Favorable preclinical profile of C-21191 supports development for pain, spasticity

Nov. 17, 2011

EB-1020 as a new approach to treat ADHD

Nov. 17, 2011

Achillion Pharmaceuticals describes second-generation NS5A inhibitors

Nov. 17, 2011

Preclinical profile of Merck & Co.'s HCV NS5A inhibitor MK-4882 described

Nov. 17, 2011

Eisai develops novel lanosterol synthase inhibitor for HCV

Nov. 17, 2011

TGase-2 correlated with reduced survival in lung cancer

Nov. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...